BIONCaRT GmbH
PrivateLast Round
Seed
Aug 21, 2024
Total Funding Raised
$1.21M
Company Overview
BIONCaRT GmbH is a biotechnology company that develops allogeneic, stem cell-based medicines for the treatment of orthopedic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BIONCaRT GmbH Comparables
Compare BIONCaRT GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FamiCord AG | 78% | |
| ReLive Biotechnologies | 77% | |
| MEDIPOST Co., Ltd. | 77% |
BIONCaRT GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 21, 2024 |
BIONCaRT GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| bm|t beteiligungsmanagement thüringen | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors grew 2012% MoM, from 25 to 528.
- Aug 21, 2024
$1.21M round led by bm|t beteiligungsmanagement thüringen.
BIONCaRT GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BIONCaRT GmbH's valuation, stock price, and market status.
Is BIONCaRT GmbH a public or private company?
BIONCaRT GmbH is a private company.
What is the current stock price of BIONCaRT GmbH?
BIONCaRT GmbH is a private company, so its shares have no public market price. Caplight tracks BIONCaRT GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BIONCaRT GmbH worth (valuation)?
Valuation information for BIONCaRT GmbH is not publicly available.
Can I buy BIONCaRT GmbH stock?
BIONCaRT GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BIONCaRT GmbH's last funding round?
BIONCaRT GmbH's most recent funding round was Seed on August 21, 2024.
Who are the main investors in BIONCaRT GmbH?
Key investors in BIONCaRT GmbH include bm|t beteiligungsmanagement thüringen.
Will BIONCaRT GmbH IPO soon?
No public IPO plans have been announced for BIONCaRT GmbH.
How can I track BIONCaRT GmbH secondary market activity?
Caplight tracks bids, offers, and trades in BIONCaRT GmbH's shares on secondary markets.